标题
The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
作者
关键词
-
出版物
Essays in Biochemistry
Volume 67, Issue 6, Pages 991-1002
出版商
Portland Press Ltd.
发表日期
2023-07-28
DOI
10.1042/ebc20230001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer
- (2023) Maria Zagorulya et al. IMMUNITY
- Targeting TBK1 to overcome resistance to cancer immunotherapy
- (2023) Yi Sun et al. NATURE
- IFNγ signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells
- (2023) Julie M. Mazet et al. Nature Communications
- Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction
- (2023) Jingya Qiu et al. Nature Cancer
- Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
- (2023) Katie M. Campbell et al. CANCER CELL
- Mutations in IFN-γ signaling genes sensitize tumors to immune checkpoint blockade
- (2023) Eric Song et al. CANCER CELL
- TGFβ Antagonizes IFNγ-Mediated Adaptive Immune Evasion via Activation of the AKT–Smad3–SHP1 Axis in Lung Adenocarcinoma
- (2023) Fan Ye et al. CANCER RESEARCH
- IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy
- (2023) Laurent Beziaud et al. Cell Stem Cell
- Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
- (2023) Arvind Ravi et al. NATURE GENETICS
- The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
- (2023) Su Yin Lim et al. Nature Communications
- EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1
- (2023) Yihui Pan et al. Advanced Science
- Disrupting the phase separation of KAT8–IRF1 diminishes PD-L1 expression and promotes antitumor immunity
- (2023) Yuanzhong Wu et al. Nature Cancer
- An adverse tumor-protective effect of IDO1 inhibition
- (2023) Juliana C.N. Kenski et al. Cell Reports Medicine
- Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
- (2022) Nathan E. Reticker-Flynn et al. CELL
- The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
- (2022) Lisa Cucolo et al. IMMUNITY
- In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
- (2022) Juan Dubrot et al. NATURE IMMUNOLOGY
- Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling
- (2022) Hongxing Shen et al. Nature Communications
- N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy
- (2022) Julia Krug et al. GASTROENTEROLOGY
- The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity
- (2022) Sabelo Lukhele et al. IMMUNITY
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
- (2021) Kevin Litchfield et al. CELL
- Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation
- (2021) Man Yu et al. MOLECULAR CELL
- Down-regulation of A20 promotes immune escape of lung adenocarcinomas
- (2021) Kristina Breitenecker et al. Science Translational Medicine
- Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
- (2020) Jason B. Williams et al. Nature Communications
- Tim-3 finds its place in the cancer immunotherapy landscape
- (2020) Nandini Acharya et al. Journal for ImmunoTherapy of Cancer
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
- (2020) Catherine S. Grasso et al. CANCER CELL
- Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
- (2020) Anusha Kalbasi et al. Science Translational Medicine
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- Low-dose IFN-γ induces tumor cell stemness in the tumor microenvironment of non-small cell lung cancer
- (2019) Mengjia Song et al. CANCER RESEARCH
- Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
- (2019) David W. Vredevoogd et al. CELL
- LNK suppresses interferon signaling in melanoma
- (2019) Ling-Wen Ding et al. Nature Communications
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
- (2019) Joseph L. Benci et al. CELL
- JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression
- (2019) Julian Mohrherr et al. INTERNATIONAL JOURNAL OF CANCER
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
- (2019) David Liu et al. NATURE MEDICINE
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- IFN-r-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via microRNA processing
- (2018) U-Ging Lo et al. CANCER RESEARCH
- Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
- (2018) Karen McLean et al. ONCOGENE
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion
- (2017) Marija Mojic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
- (2017) Kazuyoshi Takeda et al. Nature Communications
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- T Cell Intrinsic USP15 Deficiency Promotes Excessive IFN-γ Production and an Immunosuppressive Tumor Microenvironment in MCA-Induced Fibrosarcoma
- (2015) Qiang Zou et al. Cell Reports
- Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
- (2015) Roberto Bellucci et al. OncoImmunology
- Anti-proliferation Effects of Interferon-gamma on Gastric Cancer Cells
- (2014) Ying-Hui Zhao et al. Asian Pacific Journal of Cancer Prevention
- RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
- (2014) Christopher P. Dillon et al. CELL
- Inhibition of Tumor Angiogenesis by Interferon-γ by Suppression of Tumor-Associated Macrophage Differentiation
- (2014) Tao Sun et al. ONCOLOGY RESEARCH
- Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies
- (2013) Arun George Paul et al. Translational Research
- I B augments IL-12- and IL-18-mediated IFN- production in human NK cells
- (2011) Y. Kannan et al. BLOOD
- Dichotomous Effects of IFN- on Dendritic Cell Function Determine the Extent of IL-12-Driven Antitumor T Cell Immunity
- (2011) J. L. Harden et al. JOURNAL OF IMMUNOLOGY
- Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ
- (2011) Hung-Chang Chen et al. LABORATORY INVESTIGATION
- NF- B Protects Cells from Gamma Interferon-Induced RIP1-Dependent Necroptosis
- (2011) R. J. Thapa et al. MOLECULAR AND CELLULAR BIOLOGY
- Interferon-γ links ultraviolet radiation to melanomagenesis in mice
- (2011) M. Raza Zaidi et al. NATURE
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- Interferon limits the effectiveness of melanoma peptide vaccines
- (2010) H.-I. Cho et al. BLOOD
- Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
- (2009) D. J. Chung et al. BLOOD
- Interferon- -triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
- (2009) B. Jurgens et al. BLOOD
- Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages
- (2009) Dorothée Duluc et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now